País: Reino Unido
Língua: inglês
Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)
Streptokinase
CSL Behring UK Ltd
B01AD01
Streptokinase
250000unit
Powder for solution for infusion
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 02100200; GTIN: 5028360000435